funding header

Funding Opportunities


Displaying 1 - 10 of 10

 

CSSI Specific Opportunities

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)

RFA-CA-19-022
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)

RFA-CA-19-021
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)

RFA-CA-19-020
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)

RFA-CA-19-019
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional)

RFA-CA-19-027
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional)

RFA-CA-19-026
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

RFA-CA-19-025
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional)

RFA-CA-19-024
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional)

RFA-CA-19-023
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

RFA-CA-19-028
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019
Expiration Date: September 28, 2019